At present, the data concerning methylation as possible epigenetic mechanisms of SPARC deregulation in lung cancer are incomplete and correlation analysis with disease clinical course in a specific subset of patients or specific therapeutic strategies is lacking. This evidence concerns the gene SPARC and lung carcinoma.